| Literature DB >> 23324224 |
Jiri Pikula1, Pavlina Hajkova, Hana Bandouchova, Ivana Bednarova, Vojtech Adam, Miroslava Beklova, Jiri Kral, Karel Ondracek, Jitka Osickova, Miroslav Pohanka, Jana Sedlackova, Hana Skochova, Jakub Sobotka, Frantisek Treml, Rene Kizek.
Abstract
BACKGROUND: Lead, a serious threat for raptors, can hamper the success of their conservation. This study reports on experience with accidental lead intoxication and responses to chelation therapy in captive Cinereous (Aegypius monachus) and Egyptian (Neophron percnopterus) Vultures.Entities:
Mesh:
Substances:
Year: 2013 PMID: 23324224 PMCID: PMC3566908 DOI: 10.1186/1746-6148-9-11
Source DB: PubMed Journal: BMC Vet Res ISSN: 1746-6148 Impact factor: 2.741
Figure 1Radiographic evidence of lead particles in the digestive tract. Radiopaque material present within the crop and stomach (highlighted by circles) of a male Egyptian Vulture (Neophron percnopterus), lateral projection.
Figure 2Development of blood lead levels in Cinereous Vultures N = 6 in healthy Pb-non-exposed controls, n = 8 in birds sampled at the time of diagnosis, at the time of and one month after CaNa2EDTA injection (pre-and-post-treatment birds, respectively) and 8 months after exposure to lead; * = p < 0.05, ** = p < 0.01 when compared against the healthy control group.
Blood parameters of healthy Pb-non-exposed birds and Cinereous Vultures prior to and after therapy for lead toxicosis using CaNa
| | | ||
|---|---|---|---|
| Ca (mmol/l) | 2.83 ± 0.35 | 2.74 ± 0.25 | 2.50 ± 0.35 |
| P (mmol/l) | 1.28 ± 0.15 | 1.30 ± 0.27 | 0.96 ± 0.35 |
| Fe (μmol/l) | 13.55 ± 3.27 | 10.57 ± 1.74 | 5.40 ± 2.65** |
| Hb (g/l) | 147.00 ± 27.12 | 112.12 ± 19.85 | 132.71 ± 24.06 |
| Ht (l/l) | 0.50 ± 0.04 | 0.36 ± 0.06* | 0.42 ± 0.08 |
| TP (g/l) | 35.51 ± 6.40 | 30.80 ± 5.49 | 32.21 ± 4.82 |
| UAC (μmol/l) | 578.85 ± 202.97 | 872.30 ± 35.43 | 731.85 ± 327.45 |
| AST (μkat/l) | 6.78 ± 1.54 | 7.81 ± 1.90 | 5.74 ± 2.77 |
| ALP (μkat/l) | 0.64 ± 0.21 | 1.00 ± 1.62 | 3.71 ± 1.34* |
| CK (μkat/l) | 13.53 ± 6.58 | 41.04 ± 10.54* | 10.63 ± 0.94 |
| LDH (μkat/l) | 7.82 ± 0.94 | 8.06 ± 4.81 | 13.17 ± 8.62 |
| TBIL (μmol/l) | 13.10 ± 2.29 | 10.60 ± 1.50 | 7.81 ± 2.48 |
| TBARS (nmol/l) | 1.94 ± 0.12 | 7.00 ± 0.80** | 7.31 ± 0.45** |
| FRAP (μmol/l) | 1619.41 ± 34.00 | 1046.22 ± 362.14** | 1516.75 ± 451.43 |
| MT (μg/mg protein) | 1.43 ± 0.16 | 1.79 ± 0.40 | 1.92 ± 0.20* |
| GSH (μg/ml) | 1.00 ± 0.05 | 1.07 ± 0.12 | 0.79 ± 0.03* |
| GSSG (μg/ml) | 0.11 ± 0.04 | 0.05 ± 0.01* | 0.01 ± 0.001** |
Values represent mean ± SD; n = 6 in healthy Pb-non-exposed birds (3 males and 3 females), n = 8 in pre-and-post-treatment birds; * = p < 0.05, ** = p < 0.01 when compared against control group. The pre-and-post-treatment birds were blood sampled at the time of and one month after Ca-EDTA therapy, respectively. Ca = calcium, P = phosphorus, Fe = iron, Hb = haemoglobin, Ht = haematocrit, TP = total protein, UAC = uric acid, AST = aspartate aminotransferase, ALP = alkaline phosphatase, CK = creatine kinase, LDH = lactate dehydrogenase, TBIL = total bilirubin, TBARS = thiobarbituric acid reactive species, FRAP = ferric reducing ability of plasma, MT = metallothionein, GSH = reduced glutathione, GSSG = oxidised glutathione.